Article Details

FDA Grants Breakthrough Designation for EvoLiver in HCC - Targeted Oncology

Retrieved on: 2025-04-24 17:06:37

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Breakthrough Designation for EvoLiver in HCC - Targeted Oncology. View article details on hiswai:

Summary

The article discusses Mursla Bio's EvoLiver test, highlighting its use of extracellular vesicles for improved surveillance of hepatocellular carcinoma in high-risk patients with cirrhosis. This relevance ties into tags like liver cancer, cirrhosis, and liver function.

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo